Roble Belko & Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36K Buy
784
+8
+1% +$367 0.01% 197
2025
Q1
$47K Buy
776
+676
+676% +$40.9K 0.01% 175
2024
Q4
$6K Hold
100
﹤0.01% 269
2024
Q3
$5K Hold
100
﹤0.01% 255
2024
Q2
$4K Hold
100
﹤0.01% 262
2024
Q1
$5K Hold
100
﹤0.01% 263
2023
Q4
$5K Hold
100
﹤0.01% 259
2023
Q3
$6K Hold
100
﹤0.01% 232
2023
Q2
$6K Hold
100
﹤0.01% 230
2023
Q1
$7K Sell
100
-160
-62% -$11.2K ﹤0.01% 237
2022
Q4
$19K Hold
260
﹤0.01% 214
2022
Q3
$18K Hold
260
﹤0.01% 205
2022
Q2
$20K Sell
260
-250
-49% -$19.2K ﹤0.01% 200
2022
Q1
$37K Buy
510
+250
+96% +$18.1K 0.01% 178
2021
Q4
$16K Hold
260
﹤0.01% 233
2021
Q3
$15K Sell
260
-1
-0.4% -$58 ﹤0.01% 227
2021
Q2
$17K Hold
261
﹤0.01% 233
2021
Q1
$16K Hold
261
﹤0.01% 222
2020
Q4
$16K Hold
261
﹤0.01% 202
2020
Q3
$16K Sell
261
-300
-53% -$18.4K ﹤0.01% 204
2020
Q2
$33K Buy
561
+250
+80% +$14.7K 0.01% 164
2020
Q1
$17K Hold
311
0.01% 199
2019
Q4
$20K Hold
311
0.01% 211
2019
Q3
$16K Hold
311
﹤0.01% 222
2019
Q2
$14K Hold
311
﹤0.01% 232
2019
Q1
$15K Sell
311
-6,490
-95% -$313K 0.01% 186
2018
Q4
$353K Buy
6,801
+6,491
+2,094% +$337K 0.14% 54
2018
Q3
$19K Hold
310
0.01% 165
2018
Q2
$17K Sell
310
-538
-63% -$29.5K 0.01% 175
2018
Q1
$54K Buy
848
+73
+9% +$4.65K 0.02% 119
2017
Q4
$47K Buy
775
+415
+115% +$25.2K 0.02% 116
2017
Q3
$23K Buy
360
+160
+80% +$10.2K 0.01% 130
2017
Q2
$11K Hold
200
0.01% 177
2017
Q1
$11K Hold
200
0.01% 181
2016
Q4
$12K Sell
200
-765
-79% -$45.9K 0.01% 189
2016
Q3
$52K Buy
965
+775
+408% +$41.8K 0.03% 111
2016
Q2
$14K Sell
190
-225
-54% -$16.6K 0.01% 174
2016
Q1
$27K Buy
415
+265
+177% +$17.2K 0.02% 120
2015
Q4
$10K Buy
150
+50
+50% +$3.33K 0.01% 144
2015
Q3
$6K Hold
100
﹤0.01% 154
2015
Q2
$7K Hold
100
﹤0.01% 166
2015
Q1
$6K Buy
+100
New +$6K ﹤0.01% 177